- AbbVie deal may conclude a tumultuous 4 years for Botox-maker AllerganCNBC
- AbbVie to Purchase Botox Maker Allergan in $63 Billion DealBloomberg Markets and Finance
- AbbVie Strikes Deal to Acquire Allergan for About $63 BillionThe Wall Street Journal
- Humira and Botox, a Match Made in Patent HeavenBloomberg
- A Drug Megamerger That’s Patently InterestingBloomberg
- View full coverage on Google News